-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
BriaCell Therapeutics Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q4 2021 to Q1 2024.
- BriaCell Therapeutics Corp. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending April 30, 2024 was 16M shares, a 2.99% increase year-over-year.
- BriaCell Therapeutics Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 15.6M shares, a 0.81% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)